Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Congenital nasal pyriform aperture stenosis is a rare cause of pediatric nasal airway obstruction. As infants are obligate nasal breathers, nasal obstruction and even severe
nasal congestion
can lead to apnea and respiratory distress. Congenital nasal pyriform aperture stenosis was first described by
Brown
et al in 1989. The narrowing of the nasal pyriform aperture is thought to be due to bony overgrowth of the nasal process of the maxilla during fetal development. Because of the association this anomaly has with other midline defects, such as holoprosencephaly, it is important to recognize it and pursue a thorough workup. We present a case of a patient with pyriform aperture stenosis and solitary central megaincisor. This patient initially presented to our clinic with a history of nasal airway obstruction, poor feeding, and failure to thrive.
...
PMID:Congenital nasal pyriform aperture stenosis. 1112 5
The aim of this study was to develop and characterize a new model for evaluating
nasal congestion
in rats by using whole body plethysmography (WBP)-free moving application.
Brown
Norway rats were sensitized with 10% toluene-2, 4-diisocyanate (TDI) solution, and
nasal congestion
was provoked with 5% TDI. An increase in the enhanced pause (Penh) was recognized after being challenged with TDI. In addition, a significant increase in the Penh was observed following the intranasal application of histamine in TDI sensitized rats. Histamine H1 antagonists, such as chlorpheniramine and ketotifen suppressed the increase of Penh during the early-phase response. On the other hand, epinastine suppressed the increase of Penh in both the early and late phase responses. In conclusion, we developed an allergic rhinitis model that includes
nasal congestion
symptoms in
Brown
Norway rats, and this model may be useful for evaluating the effects of drugs on
nasal congestion
.
...
PMID:Nasal congestion model in Brown Norway rats and the effects of some H1-antagonists. 1654 6
The aim of this study was to investigate the involvement of chemical mediators in a
nasal congestion
model in
Brown
Norway (BN) rats. For the above purpose, we studied the effects of pranlukast and zafirlukast (cysteinyl leukotriene (cys-LT) receptor antagonists), seratrodast and ramatroban (thromboxane A(2) (TXA(2)) receptor antagonists) on
nasal congestion
and sneezing induced by toluene 2, 4-diisocyanate (TDI). All of these drugs suppressed the increase of enhanced pause (Penh), the index of
nasal congestion
, in both early and late phase responses; however, pranlukast, zafirlukast and seratrodast failed to suppress immediate sneezing caused by TDI challenge. These results indicate that cys-LTs and TXA(2) are responsible for the development of both early and late phase
nasal congestion
. Moreover, these chemical mediators contribute very little to immediate sneezing in a BN rat model of allergic rhinitis.
...
PMID:Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats. 1776 52
The aim of the present study was to clarify the involvement of prostaglandin E(2) (PGE(2)) in
nasal congestion
in
Brown
Norway (BN) rats. For this purpose, we studied the effects of PGE(2) receptor (EP(1), EP(2), EP(3) and EP(4)) agonists on
nasal congestion
and sneezing induced by toluene 2,4-diisocyanate (TDI). Enhanced pause (Penh) was increased 1 h (early phase) and 4 h (late phase) after TDI challenge. Sulprostone (an EP(3) receptor agonist) inhibited the increase of Penh, an index of
nasal congestion
, in both early and late phase responses. On the other hand, PGE(1) alcohol (an EP(4) agonist) increased Penh in the early phase response. Moreover, sulprostone inhibited sneezing, an immediate response by TDI challenge. These results indicate that EP(3) receptor is responsible for the relief of
nasal congestion
in both early and late phase responses, and EP(4) receptor is correlated with the development of
nasal congestion
in the early phase response. In addition, EP(3) receptor also participates in sneezing in allergic rhinitis induced by TDI challenge in BN rats.
...
PMID:Participation of prostaglandin E2 receptor in nasal congestion of Brown Norway rats. 2004 37